Literature DB >> 19188985

mhFLIM: resolution of heterogeneous fluorescence decays in widefield lifetime microscopy.

S Schlachter1, A D Elder, A Esposito, G S Kaminski, J H Frank, L K van Geest, C F Kaminski.   

Abstract

Frequency-domain fluorescence lifetime imaging microscopy (FD-FLIM) is a fast and accurate way of measuring fluorescence lifetimes in widefield microscopy. However, the resolution of multiple exponential fluorescence decays has remained beyond the reach of most practical FD-FLIM systems. In this paper we describe the implementation of FD-FLIM using a 40 MHz pulse train derived from a supercontinuum source for excitation. The technique, which we term multi-harmonic FLIM (mhFLIM), makes it possible to accurately resolve biexponential decays of fluorophores without any a priori information. The system's performance is demonstrated using a mixture of spectrally similar dyes of known composition and also on a multiply-labeled biological sample. The results are compared to those obtained from time correlated single photon counting (TCSPC) microscopy and a good level of agreement is achieved. We also demonstrate the first practical application of an algorithm derived by G. Weber [1] for analysing mhFLIM data. Because it does not require nonlinear minimisation, it offers potential for realtime analysis during acquisition.

Mesh:

Substances:

Year:  2009        PMID: 19188985     DOI: 10.1364/oe.17.001557

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  14 in total

1.  Phasor imaging with a widefield photon-counting detector.

Authors:  Ryan A Colyer; Oswald H W Siegmund; Anton S Tremsin; John V Vallerga; Shimon Weiss; Xavier Michalet
Journal:  J Biomed Opt       Date:  2012-01       Impact factor: 3.170

Review 2.  Fluorescence lifetime measurements and biological imaging.

Authors:  Mikhail Y Berezin; Samuel Achilefu
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).

Authors:  Peter E M Gibbs; Tihomir Miralem; Nicole Lerner-Marmarosh; Cicerone Tudor; Mahin D Maines
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Luminescence lifetime imaging of ultra-long room temperature phosphorescence on a smartphone.

Authors:  Zece Zhu; Ye Sun; Teng Ma; Di Tian; Jintao Zhu
Journal:  Anal Bioanal Chem       Date:  2021-03-26       Impact factor: 4.142

5.  A practical implementation of multifrequency widefield frequency-domain fluorescence lifetime imaging microscopy.

Authors:  Hongtao Chen; Enrico Gratton
Journal:  Microsc Res Tech       Date:  2013-01-07       Impact factor: 2.769

6.  FPGA-based multi-channel fluorescence lifetime analysis of Fourier multiplexed frequency-sweeping lifetime imaging.

Authors:  Ming Zhao; Yu Li; Leilei Peng
Journal:  Opt Express       Date:  2014-09-22       Impact factor: 3.894

7.  Modulated CMOS camera for fluorescence lifetime microscopy.

Authors:  Hongtao Chen; Gerhard Holst; Enrico Gratton
Journal:  Microsc Res Tech       Date:  2015-10-24       Impact factor: 2.769

8.  Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.

Authors:  Cicerone Tudor; Joost te Riet; Christina Eich; Rolf Harkes; Nick Smisdom; Jessica Bouhuijzen Wenger; Marcel Ameloot; Matthew Holt; Johannes S Kanger; Carl G Figdor; Alessandra Cambi; Vinod Subramaniam
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

9.  Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.

Authors:  Peter E M Gibbs; Cicerone Tudor; Mahin D Maines
Journal:  Front Pharmacol       Date:  2012-03-13       Impact factor: 5.810

Review 10.  The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Authors:  Muireann T Kelleher; Gilbert Fruhwirth; Gargi Patel; Enyinnaya Ofo; Frederic Festy; Paul R Barber; Simon M Ameer-Beg; Borivoj Vojnovic; Cheryl Gillett; Anthony Coolen; György Kéri; Paul A Ellis; Tony Ng
Journal:  Target Oncol       Date:  2009-09-16       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.